Our work shows that the PI3K p110δ plays a prominent role in breast cancer progression and that pharmacological inactivation of p110δ in mouse experimental models prevents breast tumour growth and metastasis by targeting both cancer cells and macrophages. Here, PIK3CD is linked to breast neoplasm.